P3 Health Partners (NASDAQ:PIII) Trading Up 3% – Here’s Why

P3 Health Partners Inc. (NASDAQ:PIII) traded up 3% during trading on Monday . The stock traded as high as $9.08 and last traded at $8.91. 7,700 shares changed hands during mid-day trading, a decline of 13% from the average session volume of 8,897 shares. The stock had previously closed at $8.65.

Analysts Set New Price Targets

PIII has been the subject of several analyst reports. Lake Street Capital initiated coverage on shares of P3 Health Partners in a report on Thursday, August 28th. They issued a “buy” rating and a $20.00 target price for the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of P3 Health Partners in a research report on Saturday, September 27th. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, P3 Health Partners presently has an average rating of “Hold” and a consensus price target of $16.25.

P3 Health Partners Stock Performance

The company has a quick ratio of 0.31, a current ratio of 0.31 and a debt-to-equity ratio of 2.29. The business has a 50 day moving average price of $8.00 and a two-hundred day moving average price of $7.77. The stock has a market cap of $64.06 million, a P/E ratio of -0.19 and a beta of 0.84.

P3 Health Partners (NASDAQ:PIII) last posted its quarterly earnings results on Thursday, August 14th. The company reported ($6.23) EPS for the quarter, missing analysts’ consensus estimates of ($3.29) by ($2.94). P3 Health Partners had a negative return on equity of 183.60% and a negative net margin of 9.99%.The business had revenue of $355.79 million during the quarter, compared to analysts’ expectations of $356.52 million. P3 Health Partners has set its FY 2025 guidance at EPS. On average, sell-side analysts forecast that P3 Health Partners Inc. will post -0.67 earnings per share for the current fiscal year.

Institutional Trading of P3 Health Partners

A number of institutional investors and hedge funds have recently bought and sold shares of PIII. Cresset Asset Management LLC lifted its stake in P3 Health Partners by 33.3% in the 1st quarter. Cresset Asset Management LLC now owns 200,000 shares of the company’s stock worth $33,000 after purchasing an additional 50,000 shares in the last quarter. Abundance Wealth Counselors increased its holdings in shares of P3 Health Partners by 77.3% in the first quarter. Abundance Wealth Counselors now owns 400,000 shares of the company’s stock worth $66,000 after purchasing an additional 174,395 shares during the last quarter. Finally, Trinity Financial Advisors LLC lifted its position in shares of P3 Health Partners by 22.5% in the first quarter. Trinity Financial Advisors LLC now owns 1,278,037 shares of the company’s stock worth $222,000 after buying an additional 234,500 shares in the last quarter. 7.75% of the stock is currently owned by institutional investors.

About P3 Health Partners

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.